RT Journal Article SR Electronic T1 NAD+ repletion rescues female fertility during reproductive ageing JF bioRxiv FD Cold Spring Harbor Laboratory SP 721985 DO 10.1101/721985 A1 Michael J. Bertoldo A1 Dave R. Listijono A1 Wing-Hong Jonathan Ho A1 Angelique H. Riepsamen A1 Xing L. Jin A1 Kaisa Selesniemi A1 Dale M. Goss A1 Saabah Mahbub A1 Jared M. Campbell A1 Abbas Habibalahi A1 Wei-Guo Nicholas Loh A1 Neil A. Youngson A1 Jayanthi Maniam A1 Ashley S.A. Wong A1 Dulama Richani A1 Catherine Li A1 Yiqing Zhao A1 Maria Marinova A1 Lynn-Jee Kim A1 Laurin Lau A1 Rachael M Wu A1 A. Stefanie Mikolaizak A1 Toshiyuki Araki A1 David G. Le Couteur A1 Nigel Turner A1 Margaret J. Morris A1 Kirsty A. Walters A1 Ewa Goldys A1 Christopher O’Neill A1 Robert B. Gilchrist A1 David A. Sinclair A1 Hayden A. Homer A1 Lindsay E. Wu YR 2019 UL http://biorxiv.org/content/early/2019/08/02/721985.abstract AB Female infertility is a common and devastating condition with life-long health, emotional and social consequences. There is currently no pharmacological therapy for preserving oocyte quality during aging, which is the strongest risk factor for infertility. This leads to an age dependent decline in natural conception and IVF success rates (1). Here, we show that this is due in part to declining levels of the metabolic cofactor nicotinamide adenine dinucleotide (NAD+), and that restoring NAD+ levels with its metabolic precursor nicotinamide mononucleotide (NMN) rejuvenates oocyte quality and quantity in aged animals, leading to improved fertility. These benefits extend to the developing embryo, where NMN supplementation in embryo culture media following IVF enhances blastocyst formation in older mice. The NAD+ dependent deacylase SIRT2 is sufficient, but not essential, to recapitulate the benefits of in vivo NMN treatment, and transgenic overexpression of SIRT2 maintains oocyte spindle assembly, accurate chromosome segregation, decreased oxidative stress and overall fertility with ageing. Pharmacological elevation of NAD+ may be an effective, non-invasive strategy for restoring and maintaining female fertility during ageing, and for improving the success of IVF.